-+ 0.00%
-+ 0.00%
-+ 0.00%

Harmony Acquisitions Receives Conditional TSXV Approval for Vimy Pharma Acquisition

PUBT·11/06/2026 21:25:53
Listen to the news
Harmony Acquisitions Receives Conditional TSXV Approval for Vimy Pharma Acquisition
  • Harmony Acquisitions received conditional TSX Venture Exchange approval for its previously announced acquisition of all outstanding shares of Vimy Pharma.
  • Closing is expected on or about November 12, 2026, subject to final exchange acceptance and other customary closing conditions.
  • The combined company is expected to trade on the TSX Venture Exchange as Vimy Pharmaceuticals under the ticker VIMY.
  • Vimy Pharma develops generic medicines, including versions of Ozempic and Wegovy submitted to Health Canada for review.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harmony Acquisitions Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611061625NEWSFILECNPR____20261106_322950_1) on November 06, 2026, and is solely responsible for the information contained therein.